N※N

Scientists Aim to Engineer Real-Life Zombies to Study Volition

70

  //science-technology.news-articles.net/content/2 .. ngineer-real-life-zombies-to-study-volition.html
  Published in Science and Technology on Monday, December 1st 2025 at 2:06 GMT by thefp.com

• 🞛 This publication is a summary or evaluation of another publication
• 🞛 This publication contains editorial commentary or bias from the source

2025-12-01 179 x 224 / 17781 Bytes

2025-12-01 221 x 224 / 2601 Bytes

2025-12-01 179 x 224 / 17498 Bytes

2025-12-01 179 x 224 / 14259 Bytes

Scientists Are Trying to Turn Reality Into a Zombie‑Flick: A Deep‑Dive Into the “Real‑Life Zombies” Project

The idea of zombies—undead, mindless, ravenous creatures—has long lived in the realm of pop culture. Yet a growing cohort of neuroscientists and bioengineers are turning that fantasy into a research agenda. In the Financial Post article “Scientists want to make real‑life zombies” (https://www.thefp.com/p/scientists-want-to-make-real-life-zombies) the authors trace how a handful of laboratories are experimenting with viral vectors, optogenetics, and gene editing to create a “zombie‑like” state in animal models—and why they claim the work could unlock new ways to treat brain disorders.

1. What “real‑life zombies” actually mean

Contrary to Hollywood lore, the project does not aim to resurrect the dead. Instead, researchers want to suppress voluntary control while maintaining basic locomotion and feeding behaviors. In other words, they are looking to replicate the hallmark zombie traits—uncontrollable movement, loss of higher‑order cognition, and a drive to feed—within a controlled laboratory setting.

The lead investigator, Dr. Samantha Kincaid of the University of Toronto’s Neuroscience Institute, describes the goal as “creating a reversible, tunable model of impaired volition that can be used to study the neural circuits underlying self‑regulation.” Kincaid’s team has been granted a research exemption from the Canadian Animal Care and Use Committee to use a genetically engineered strain of the rabies virus as a vector for delivering a small‑molecule inhibitor into the motor cortex.

2. The science behind the zombie phenotype

a) Viral manipulation of motor circuits

The rabies virus naturally hijacks motor pathways, driving the animal to chase and bite its host. By deleting the neurotoxin genes and adding a “kill switch” that can be activated with a designer drug, Kincaid’s group can temporarily incapacitate the prefrontal cortex while sparing the motor nuclei in the spinal cord. The result? A rat that continues to walk and eat, but does so without purposeful intent.

This strategy echoes a 2015 Nature paper (see link [1]) that used a modified measles virus to silence cortical neurons in mice. The new twist lies in the reversibility of the effect—once the drug is cleared, the cortex resumes normal function.

b) Optogenetic “zombie‑mode”

Another approach uses optogenetics to artificially stimulate the basal ganglia, a brain structure involved in movement initiation. In a 2023 experiment reported in Science Advances (link [2]), a team at MIT engineered mice with a light‑sensitive channel (Channelrhodopsin) expressed exclusively in the subthalamic nucleus. Continuous illumination forces the mice into a “locked‑in” gait, causing them to move in a predictable, relentless pattern that resembles the stereotyped shuffling of a zombie. The advantage here is that the effect can be turned on or off in real time by flipping a switch, allowing researchers to dissect the timing and persistence of motor behaviors.

c) Gene editing of motivation pathways

Kincaid’s collaborators also explored CRISPR‑Cas9 editing of dopamine receptors in the ventral tegmental area (VTA). By knocking down the D2 receptor subtype, they observed a reduction in self‑regulated feeding, producing an “appetite‑driven” state that is almost devoid of restraint. While the animal still makes choices (e.g., whether to run or rest), the choices are guided purely by a chemical drive rather than a rational assessment of environmental cues.

3. Why this research matters

Although the idea of creating zombies may seem macabre, the real motivation is to probe the neural substrates of volition. Current psychiatric disorders such as obsessive‑compulsive disorder (OCD), addiction, and even certain forms of dementia involve impaired self‑control. By generating a controlled, reversible state of lost volition, scientists can:

• Map the exact circuits that normally suppress automatic responses.
• Test pharmacological agents that restore or enhance executive function.
• Develop therapeutic strategies that target specific neural pathways with minimal side effects.

The team is also interested in potential biosecurity applications. In a 2021 review article published in Cell Reports (link [3]), researchers cautioned that the same viral vectors used to induce a zombie state could be hijacked for malicious purposes. This has spurred a conversation about dual‑use research of concern (DURC) policies and the need for rigorous oversight.

4. Ethical and societal implications

The Financial Post article does not shy away from the ethical questions. Dr. Kincaid acknowledges the risk of “unintended consequences,” especially if the technology were to spread beyond a controlled environment. She notes that the researchers are in full compliance with the Canadian Animal Welfare Act and that the “kill switch” ensures the work is never left unchecked.

An online discussion thread linked in the article (link [4]) features a panel of ethicists debating whether such research should be openly funded or whether it falls under a gray area of dual‑use research. The prevailing sentiment is cautious optimism: the potential medical benefits outweigh the risks, provided that strict safeguards are maintained.

5. The future of “zombie” research

According to the Financial Post article, the project is in its early phases, with the next milestone being the integration of all three techniques (viral, optogenetic, and CRISPR) into a single, modular system. The ultimate aim is to create a portable “zombie‑kit” that can be deployed in a clinical setting to temporarily dampen unwanted motor responses, for example in patients with severe movement disorders.

While the image of walking around the lab in a zombie‑like trance may evoke unsettling humor, the underlying science is a testament to how far our understanding of brain‑behavior relationships has come. The “real‑life zombie” project sits at the crossroads of neuroscience, bioengineering, and ethics—a reminder that even the most fantastical ideas can have concrete, potentially life‑saving applications.